Literature DB >> 8224688

Polyethylene pancreatic duct stent-induced changes in the normal dog pancreas.

S Sherman1, C Alvarez, M Robert, S W Ashley, H A Reber, G A Lehman.   

Abstract

This study was undertaken to evaluate the frequency, severity, and reversibility of stent-induced pancreatic ductal and parenchymal changes in the normal dog pancreas. Six adult mongrel dogs underwent duodenotomy and placement of 5F polyethylene pancreatic duct stents into the main pancreatic duct. After 8 weeks of stenting, the animals were randomly assigned to one of three groups: group I (n = 2), sacrifice; group II (n = 2), stent removal followed by sacrifice after an 8-week recovery period; group III (n = 2), the stent was exchanged and kept in place for an additional 8 weeks. In group III at 16 weeks the stent was removed, and the animals were allowed to recover for 8 weeks before sacrifice. Pancreatograms were obtained at each operation and were normal before stent placement. Gross and histologic evaluation was performed at the time of sacrifice. All stented animals developed radiographic, gross, and histologic abnormalities. Pancreatograms showed duct dilation in the stented region associated with a short stenosis at the mid to upstream segment of the stent. Group III animals had more advanced radiographic changes than group I and II animals. The radiographic findings were associated with gross evidence of fibrosis, which increased proportionately with the length of the stenting period. Group III animals developed moderate to severe pancreas atrophy. Histologic changes of obstructive pancreatitis were present in most experimental dogs. The results of this study suggest that pancreatic stenting may cause permanent damage in the normal dog pancreas. The cause of the damage appears to be related to stent occlusion, perhaps exacerbated by local stent-induced trauma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8224688     DOI: 10.1016/s0016-5107(93)70218-7

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  10 in total

1.  Progress in endoscopic management of pancreas diseases.

Authors:  Zhao-Shen Li
Journal:  World J Gastroenterol       Date:  1998-04       Impact factor: 5.742

2.  Pancreatic Duct Strictures.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-10

3.  Proximal migration of transanastomotic pancreatic stent following pancreaticoduodenectomy and pancreaticojejunostomy.

Authors:  B J Ammori; C M White
Journal:  Int J Pancreatol       Date:  1999-06

Review 4.  Endotherapy for chronic pancreatitis.

Authors:  R A Kozarek; L W Traverso
Journal:  Int J Pancreatol       Date:  1996-04

Review 5.  Biocompatible Polymer Materials with Antimicrobial Properties for Preparation of Stents.

Authors:  Kateřina Škrlová; Kateřina Malachová; Alexandra Muñoz-Bonilla; Dagmar Měřinská; Zuzana Rybková; Marta Fernández-García; Daniela Plachá
Journal:  Nanomaterials (Basel)       Date:  2019-10-31       Impact factor: 5.076

Review 6.  Endoscopic prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Tae Hoon Lee; Do Hyun Park
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

7.  Endoscopic approach to pancreas divisum.

Authors:  R A Kozarek; T J Ball; D J Patterson; J J Brandabur; S L Raltz
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

8.  Transpapillary stenting for pancreaticocutaneous fistulas.

Authors:  R A Kozarek; T J Ball; D J Patterson; S L Raltz; L W Traverso; J A Ryan; R C Thirlby
Journal:  J Gastrointest Surg       Date:  1997 Jul-Aug       Impact factor: 3.452

Review 9.  Endoscopic pancreatic duct stent placement for inflammatory pancreatic diseases.

Authors:  Pier-Alberto Testoni
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

10.  Outcome of lateral pancreaticojejunostomy in the management of chronic pancreatitis with nondilated pancreatic ducts.

Authors:  G A Rios; D B Adams; K G Yeoh; P R Tarnasky; J T Cunningham; R H Hawes
Journal:  J Gastrointest Surg       Date:  1998 May-Jun       Impact factor: 3.267

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.